参考文献/References:
[1] Shiobara M, Miyazaki M, Ito H, et al. Enhanced polyadenosine diphosphate-ribosylation in cirrhotic liver and carcinoma tissues in patients with hepatocellular carcinoma[J]. J Gastroenterol Hepatol, 2001, 16(3):338-344.
[2] Bryant HE, Schultz N, Thomas HD, et al. Specific killing of BRCA2-defieient tumours with inhibitors of poly (ADP-ribose) polymerase[J]. Nature, 2005, 434(7035):913-917.
[3] Farmer H, McCabe N, Lord C J, et al. Targeting the DNA repair defect in BRCA mutant cells as a therapeutic slrategy[J]. Nature, 2005, 434(7035):917-921.
[4] Calabrese CR, Almassy R, Barton S, et al. Anticancer chemosensiti-zation and radiosensitization by the novel poly (ADP-ribose) polymerase-1 inhibitor AG14361[J]. J Natl Cancer lnst, 2004,96(1):56-67.
[5] Chalmers A, Johnston P, Woodcock M, et al. PARP-1, PARP-2, and the cellular response to low doses of ionizing radiation[J].Int J Radiat Oncol Biol Phys, 2004, 58(2):410-419.
[6] Brock WA, Milas L, Bergh S, et al. Radiosensitization of human and rodent celllines by INO-1001, a novel inhibitor of poly(ADP-ribose) polymerase[J]. Cancer Lett, 2004, 205(2):155-160.
[7] Noël G, Godon C, Femet M, et al. Radiosensitization by the poly (ADP-ribose)polymerase inhibitor 4-amino-1, 8-naphthalimide is specific of the S phase of the cell cycle and involves arrest of DNA synthesis[J]. Mol Cancer Ther, 2006, 5(3):564-574.
[8] Veuger SJ, Curtin N J, Richardson C J, et al. Radiosensitization and DNA repair inhibition by the combined use of novel inhibitors of DNA-dependent protein kinase and poly(ADP-ribose)polymerase-1[J]. Cancer Res, 2003, 63(18):6008-6015.
[9] Carla H, Quintas A, Chaveea T, et al. The role of poly(ADP-ribose) polymerase in the induction of sister chromatid exchanges and micronuclei by mitomyein C in Dowm’s syndrome cells as compared to euploid cells[J]. Murat Res, 1997, 377(2):269-277.
[10] Tentori L, Leonetti C, Scarsella M, et al. Combined treatment with temozolomide and poly(ADP-ribose)polymerase inhibitor enhances survival of mice bearing hematological malignancy at the CNS site[J]. Blood, 2002,99(6):2241-2244.
[11] Miknyoczki SJ, Jones-Bolin S, Pritchard S, et al. Chemopotentiation of temozolomide, irinotecan, and cisplatin activity by CEP-6800, a poly(ADP-ribose) polymerase inhibitor[J]. Mol Cancer Ther, 2003, 2(4):371-382.
[12] Tentori L, Balduzzi A, Portarena I, et al. Poly (ADP-ribose)polymer-ase inhibitor increases apoptosis and reduces necrosis induced by a DNA minor groove binding methyl sulfonate ester[J]. Cell Death Differ, 2001, 8(8):817-828.
[13] Calabrese CR, Batey MA, Thomas HD, et al. Identification of potent nontoxic poly(ADP-Ribose)polymerase-1 inhibitors:chemopotentiation and pharmacological studies[J]. Clin Cancer Res, 2003, 9(7):2711-2718.
[14] Curtin NJ, Wang LZ, Yiakouvaki A, et al. Novel poly(ADP-ribose) polymerase-1 inhibitor, AG14361, restores sensitivity to temozolomide in mismatch repair-deflcient cells[J]. Clin Cancer Res, 2004, 10(3):881-889.
[15] Griffin RJ, Curtin NJ, Newell DR, et al.The role of inhibitors of poly (ADP-ribose) polymerase as resistance-modifying agents in cancer therapy[J]. Biochimie, 1995, 77(6):408-422.
[16] LaPlaca MC, Zhang J, Raghupathi R, et al. Pharmacologic inhibition of poly(ADP-ribose)polymerase is neuroprotective following traumatic brain injury in rats[J]. J Neurotrauma, 2001, 18(4):369-376.
[17] Weise J, Isenmann S, Baihr M. Increased expression and activation of poly(ADP-ribose)polymerase(PARP)contribute to retinal ganglion cell death following rat optic nerve transection[J]. Cell Death Differ, 2001, 8(8):801-807.
[18] Szabó C, Dawson VL. Role of poly (ADP-Ribose)synthetase in inflammation and ischaemia-reperfusion[J]. Trends Pharmacol Sci, 1998, 19(7):287-298.
[19] Plasehke K, Kopitz J, Weigand MA, et al. The neuroproteetive effect of cerebral poly (ADP-ribose) polymerase inhibition in a rat model global ischemia. Neurosci Lett, 2000, 284(1-2):109-112.
[20] Zingarelli B, Cuzzocrea S, Zsengeller Z, et al. Protection against myocardial ischemia and reperfusion injury by 3-aminobenzamide, an inhibitor of poly (ADP-ribose) synthetase[J]. Cardiovasc Res, 1997, 36(2):205-215.
[21] Pacher P, Liaudet L, Mabley J, et al. Pharmacologic inhibition of poly (adenosine diphosphate-ribose)polymerase may represent a novel therapeutic approach in chronic heart failure[J]. J Am Coll Cardiol, 2002, 40(5):1006-1016.
[22] Pacher P, Liaudet L, Soriano FG, et al. The role of poly (ADP-ribose)polymerase activation in the development of myocardial and endothelial dysfunction in diabetes[J]. Diabetes, 2002, 51(2):514-521.
[23] Virag L, Szabo C. The therapeutic potential of poly (ADP-ribose) polymerase inhibitors[J]. Pharmacol Rev, 2002, 54(3):375-429.
相似文献/References:
[1]刘佳,高刚,朴春南,等.调节肿瘤放射敏感性的miRNAs研究进展[J].国际放射医学核医学杂志,2016,40(2):159.[doi:10.3760/cma.j.issn.1673-4114.2016.02.015]
Liu Jia,Gao Gang,Piao Chunnan,et al.Progress of microRNAs in regulating tumor radiation sensitivity[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(2):159.[doi:10.3760/cma.j.issn.1673-4114.2016.02.015]
[2]陈晓艳,张江虹,邵春林.STAT3与辐射敏感相关性的研究进展[J].国际放射医学核医学杂志,2016,40(3):191.[doi:10.3760/cma.j.issn.1673-4114.2016.03.007]
Chen Xiaoyan,Jianghong,Shao Chunlin.Research progresses of correlation between STAT3 and radiosensitivity[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(2):191.[doi:10.3760/cma.j.issn.1673-4114.2016.03.007]
[3]殷丽娜,张旭霞,张俊香,等.Wnt/β-catenin信号通路——乳腺癌的潜在治疗靶点[J].国际放射医学核医学杂志,2014,38(4):252.[doi:10.3760/cma.j.issn.1673-4114.2014.04.011]
Yin Lina,Zhang Xuxia,Zhang Junxiang,et al.The Wnt/β-catenin signaling pathway-a potential therapeutic target of breast cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2014,38(2):252.[doi:10.3760/cma.j.issn.1673-4114.2014.04.011]
[4]丛征,郭傲,郭阳.组蛋白去乙酰酶阻滞剂的放射增敏作用[J].国际放射医学核医学杂志,2013,37(2):112.[doi:10.3760/cma.j.issn.1673-4114.2013.02.013]
CONG Zheng,GUO Ao,GUO Yang.Enhancement of radiation response by his tone deacetylase inhibitor[J].International Journal of Radiation Medicine and Nuclear Medicine,2013,37(2):112.[doi:10.3760/cma.j.issn.1673-4114.2013.02.013]
[5]李敏,孟庆慧,胡旭东,等.B细胞易位基因2的表达水平对肿瘤细胞放射敏感性的影响[J].国际放射医学核医学杂志,2013,37(3):129.[doi:10.3760/cma.j.issn.1673-4114.2013.03.001]
LI Ming,MENG Qing-hui,HU Xu-dong,et al.Effect of B-cell translocation gene 2 alteration on radiosensitivity of cancer cells[J].International Journal of Radiation Medicine and Nuclear Medicine,2013,37(2):129.[doi:10.3760/cma.j.issn.1673-4114.2013.03.001]
[6]白佳利,于程程,王德芝,等.对甲基桂皮丹酚酯抗辐射活性的研究[J].国际放射医学核医学杂志,2013,37(3):139.[doi:10.3760/cma.j.issn.1673-4114.2013.03.003]
BAI Jia-li,YU Cheng-cheng,WANG De-zhi,et al.Protective effect of P-methyl cinnamic paeonol esters against radiation damage[J].International Journal of Radiation Medicine and Nuclear Medicine,2013,37(2):139.[doi:10.3760/cma.j.issn.1673-4114.2013.03.003]
[7]陈凤华,沈秀,李德冠,等.Tat-SmacN7蛋白对食管癌109细胞辐射敏感性的影响[J].国际放射医学核医学杂志,2013,37(3):146.[doi:10.3760/cma.j.issn.1673-4114.2013.03.005]
CHEN Feng-hua,SHEN Xiu,LI De-guan,et al.The effects of Tat-SmacN7 protein on radiosensitivity of esophageal carcinoma 109[J].International Journal of Radiation Medicine and Nuclear Medicine,2013,37(2):146.[doi:10.3760/cma.j.issn.1673-4114.2013.03.005]
[8]李平,宗天舟,季晓芹,等.CD133+U87人脑胶质瘤干细胞放射敏感性和DNA双链断裂损伤修复的实验研究[J].国际放射医学核医学杂志,2013,37(3):153.[doi:10.3760/cma.j.issn.1673-4114.2013.03.007]
LI Ping,ZONG Tian-zhou,JI Xiao-qin,et al.CD133 positive U87 glioma stem cell radiosensitivity and DNA double-strand break repair[J].International Journal of Radiation Medicine and Nuclear Medicine,2013,37(2):153.[doi:10.3760/cma.j.issn.1673-4114.2013.03.007]
[9]戚瑞祥,董娟聪,卢良杰,等.Toll样受体4与肿瘤及其放射敏感性的研究进展[J].国际放射医学核医学杂志,2013,37(4):225.[doi:10.3760/cma.j.issn.1673-4114.2013.04.009]
QI Rui-xiang,DONG Juan-cong,LU Liang-jie,et al.Advance in toll-like receptor 4 and tumor and its radiosensitivity[J].International Journal of Radiation Medicine and Nuclear Medicine,2013,37(2):225.[doi:10.3760/cma.j.issn.1673-4114.2013.04.009]
[10]郭艳婷,张鹏飞,刘强.Smac与肿瘤放射治疗[J].国际放射医学核医学杂志,2013,37(5):309.[doi:10.3760/cma.j.issn.1673-4114.2013.05.014]
GUO Yan-ting,ZHANG Peng-fei,LIU Qiang.Effects of Smac on tumor radiotherapy[J].International Journal of Radiation Medicine and Nuclear Medicine,2013,37(2):309.[doi:10.3760/cma.j.issn.1673-4114.2013.05.014]